InsiderClue
← All stocks

Skye Bioscience, Inc.

SKYE Net buying
CIK 0001516551 #5235 in the set updated 17 Sep 2026
Bought (120 mo)
$125.02B
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$6.84M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$6.84M
47 of 47 sales
Net
+$125.01B
+$125.01B against sales at will

By person

14 insiders · 56 transactions
1.9×

Punit Dhillon holds only 1.9 times base salary in stock. $1.20M of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Punit Dhillon last reported holding, valued at $0.32, the price Common Stock was last bought or sold at on the open market here, on 20 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
DHILLON PUNIT
Chief Executive Officer
$100.00B (2)
$413.92K (2)
+$100.00B
3,755,544
10.60%
$1.20M
—
HEPPELL JAMES L
Director
$25.00B (1)
—
+$25.00B
500,000
1.41%
$160.00K
—
5AM Partners VII, LLC entity
10% owner
$16.53M (2)
$2.69M (19)
+$13.83M
7,850,155
22.16%
$2.51M
+155.9%
Schwab Andrew J.
Director
—
$2.69M (19)
−$2.69M
7,850,155
22.16%
$2.51M
—
Grayson Paul A.
Director
—
$432.06K (2)
−$432.06K
259,701
0.7332%
$83.10K
—
Emerald Health Sciences Inc. entity
10% owner
— (1)
$300.00K (1)
−$300.00K
169,407,901
—
$54.21M
+593.3%
ARSENAULT KAITLYN
Chief Financial Officer
—
$216.65K (2)
−$216.65K
166,342
0.4696%
$53.23K
—
Diep Tuan Tu
Chief Operating Officer
—
$97.72K (2)
−$97.72K
82,259
0.2322%
$26.32K
+7.1%
LYKOS COSMAS N
Chairman
—
—
—
4,599,400
12.98%
$1.47M
+24.3%
Lapham Reg Alexander
10% owner
—
—
—
3,787,500
10.69%
$1.21M
−3.1%
Murphy Brian Stuart
CEO, Chief Medical Officer
—
—
—
1,275,000
3.60%
$408.00K
+240.0%
Berecz Elizabeth
Chief Financial Officer
—
—
—
1,050,000
2.96%
$336.00K
+200.0%
Cesario Douglas A
CFO and Secretary
—
—
—
643,501
1.82%
$205.92K
—
Rai Sukhwinder Singh
Director
—
—
—
73,561
0.2077%
$23.54K
—

Individual transactions

47
Insider
Date
Role
Action
Shares
Price
Amount
5AM Partners VII, LLC
20 Aug 2026
10% owner
Sell indirect
6,495
$0.32
$2.08K
5AM Partners VII, LLC
20 Aug 2026
10% owner
Sell indirect
46
$0.32
$14.72
5AM Partners VII, LLC
20 Aug 2026
10% owner
Sell indirect
1,159
$0.32
$370.88
Schwab Andrew J.
20 Aug 2026
Director
Sell indirect
6,495
$0.32
$2.08K
Schwab Andrew J.
20 Aug 2026
Director
Sell indirect
46
$0.32
$14.72
Schwab Andrew J.
20 Aug 2026
Director
Sell indirect
1,159
$0.32
$370.88
5AM Partners VII, LLC
19 Aug 2026
10% owner
Sell indirect
57,476
$0.35
$20.12K
5AM Partners VII, LLC
19 Aug 2026
10% owner
Sell indirect
409
$0.35
$143.15
5AM Partners VII, LLC
19 Aug 2026
10% owner
Sell indirect
10,255
$0.35
$3.59K
Schwab Andrew J.
19 Aug 2026
Director
Sell indirect
57,476
$0.35
$20.12K
Schwab Andrew J.
19 Aug 2026
Director
Sell indirect
409
$0.35
$143.15
Schwab Andrew J.
19 Aug 2026
Director
Sell indirect
10,255
$0.35
$3.59K
5AM Partners VII, LLC
18 Aug 2026
10% owner
Sell indirect
253,080
$0.38
$96.17K
5AM Partners VII, LLC
18 Aug 2026
10% owner
Sell indirect
1,830
$0.38
$695.40
5AM Partners VII, LLC
18 Aug 2026
10% owner
Sell indirect
45,090
$0.38
$17.13K
Schwab Andrew J.
18 Aug 2026
Director
Sell indirect
253,080
$0.38
$96.17K
Schwab Andrew J.
18 Aug 2026
Director
Sell indirect
1,830
$0.38
$695.40
Schwab Andrew J.
18 Aug 2026
Director
Sell indirect
45,090
$0.38
$17.13K
5AM Partners VII, LLC
22 Aug 2025
10% owner
Sell indirect
6,470
$3.42
$22.13K
5AM Partners VII, LLC
22 Aug 2025
10% owner
Sell indirect
163,979
$3.42
$560.81K
Schwab Andrew J.
22 Aug 2025
Director
Sell indirect
6,470
$3.42
$22.13K
Schwab Andrew J.
22 Aug 2025
Director
Sell indirect
163,979
$3.42
$560.81K
5AM Partners VII, LLC
21 Aug 2025
10% owner
Sell indirect
2,314
$3.57
$8.26K
5AM Partners VII, LLC
21 Aug 2025
10% owner
Sell indirect
58,642
$3.57
$209.35K
Schwab Andrew J.
21 Aug 2025
Director
Sell indirect
2,314
$3.57
$8.26K
Schwab Andrew J.
21 Aug 2025
Director
Sell indirect
58,642
$3.57
$209.35K
Grayson Paul A.
18 Nov 2024
Director
Sell
86,244
$4.99
$430.36K
DHILLON PUNIT
18 Nov 2024
Chief Executive Officer
Sell
82,546
$4.99
$411.90K
ARSENAULT KAITLYN
18 Nov 2024
Chief Financial Officer
Sell
43,206
$4.99
$215.60K
Diep Tuan Tu
18 Nov 2024
Chief Development Officer
Sell
19,489
$4.99
$97.25K
Grayson Paul A.
15 Nov 2024
Director
Sell
307
$5.55
$1.70K
DHILLON PUNIT
15 Nov 2024
Chief Executive Officer
Sell
364
$5.55
$2.02K
ARSENAULT KAITLYN
15 Nov 2024
Chief Financial Officer
Sell
190
$5.55
$1.05K
Diep Tuan Tu
15 Nov 2024
Chief Development Officer
Sell
85
$5.55
$471.75
5AM Partners VII, LLC
13 Sep 2024
10% owner
Sell indirect
79
$6.06
$478.74
5AM Partners VII, LLC
13 Sep 2024
10% owner
Sell indirect
2,000
$6.06
$12.12K
5AM Partners VII, LLC
13 Sep 2024
10% owner
Sell indirect
11,758
$6.06
$71.25K
Schwab Andrew J.
13 Sep 2024
Director
Sell indirect
79
$6.06
$478.74
Schwab Andrew J.
13 Sep 2024
Director
Sell indirect
2,000
$6.06
$12.12K
Schwab Andrew J.
13 Sep 2024
Director
Sell indirect
11,758
$6.06
$71.25K
5AM Partners VII, LLC
11 Sep 2024
10% owner
Sell indirect
1,440
$6.60
$9.50K
5AM Partners VII, LLC
11 Sep 2024
10% owner
Sell indirect
36,504
$6.60
$240.93K
5AM Partners VII, LLC
11 Sep 2024
10% owner
Sell indirect
214,556
$6.60
$1.42M
Schwab Andrew J.
11 Sep 2024
Director
Sell indirect
1,440
$6.60
$9.50K
Schwab Andrew J.
11 Sep 2024
Director
Sell indirect
36,504
$6.60
$240.93K
Schwab Andrew J.
11 Sep 2024
Director
Sell indirect
214,556
$6.60
$1.42M
Emerald Health Sciences Inc.
7 Aug 2020
10% owner
Sell
3,000,000
$0.10
$300.00K
Show all 56 transactions →

What was left out

Form 4 filings counted 119
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 47
Transactions with no price 1
Shares from compensation/vesting 1,333,352,036
Sales filed before the plan box existed 1
History held since 28 Mar 2017